Zopiclone

This classification denotes a sedative and hypnotic with the molecular formula C17H17ClN6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03A5ORL08Q, chemically known as 4-methyl-1-piperazinecarboxylic acid ester with 6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5h-pyrrolo(3,4-b)pyrazin-5-one but generally known as zopiclone, which bears US NIH Compound Identifier 5735. European Medicines Agency schedules Zopiclone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00188MIG. The term ZOPICLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules zopiclone in its Anatomical Therapeutic Chemical (ATC) Classification. ZOPICLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zopiclone under HS 29337900 and SITC 51561. As of Q4 2014, ZOPICLONE remains the US FDA Preferred Term for this commodity. Zopiclone bears US NLM identifiers UMLS ID C0078847 and NCI Concept Code C80279. SMILES: CLC1CCC(N2C(OC(=O)N3CCN(CC3)C)C3NCCNC3C2=O)NC1.